A gloved hand holds COVID-19 testing specimen.

New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible.

June 22, 2021

ARUP Expert Leads IDSA Panel That Authored New COVID-19 Antigen Testing Guidelines

Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status

Image shows a microscopic view of circulating tumor cells.

Photo credit: kjpargeter - www.freepik.com

 
May 10, 2021

ARUP Announces Partnership with TellBio for Use of TellBio’s Novel…

SALT LAKE CITY—ARUP Laboratories today announced it has signed a strategic agreement with

Ryan Nelson, PharmD

ARUP Senior Pharmacy Consultant Ryan Nelson, PharmD, is the author of several papers aimed at helping oncologists use pharmacogenomic testing to guide treatment. He also will discuss the topic during a May 11, 2021, Patient-centered Laboratory Utilization Guidance Services/Medical Training Solutions (PLUGS/MTS) webinar.

May 5, 2021

ARUP Expert to Present Webinar on Pharmacogenomics in Cancer Care

ARUP Laboratories Senior Pharmacy Consultant Ryan Nelson, PharmD, is on a quest to share how underused pharmacogenomic

A close-up of three hands. The gloved hands draw blood from a finger of the third hand for the NanoSpot.AI rapid COVID-19 antibody test.

The NanoSpot.AI rapid COVID-19 antibody test is performed on blood collected through a finger prick using a microcollection tube. Droplets of blood are then placed on three spots on a ready-to-use, synthetic, embossed card. One of the spots displays the test result.

April 29, 2021

University of Utah, ARUP, and Techcyte Develop NanoSpot.AI, a New Ultra-…

The University of Utah, ARUP Laboratories, and Techcyte Inc. announced that they have

Adam Barker, PhD, stands in a laboratory.

Adam Barker, PhD, director of the ARUP Institute for Clinical and Experimental Pathology, will share insights on managing a clinical lab throughout a pandemic during a Dark Intelligence Group COVID-19 STAT Intelligence Briefing on Tuesday, April 27.

April 23, 2021

Dark Intelligence Group COVID-19 Briefing to Feature ARUP Expert

ARUP’s Adam Barker, PhD, will be the featured presenter during the Dark Intelligence Group’s COVID-19 STAT

Patricia Slev, PhD, ARUP Immunology Division section chief and University of Utah associate professor of pathology sits at a desk

March 29, 2021

ARUP Section Chief Plays Key Role in New Guidelines Detailing Use,…

Patricia Slev, PhD, ARUP Immunology Division section chief and University of Utah associate